LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy

MLA

Park, Gaeul, et al. “LDR-Induced MiR-30a and MiR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy.” Molecular Therapy, no. Preprints, Jan. 2024. EBSCOhost, https://doi.org/10.1016/j.ymthe.2018.10.015.

APA

Park, G., Son, B., Kang, J., Lee, S., Jeon, J., Kim, J.-H., Yi, G.-R., Youn, H., Moon, C., Nam, S. Y., & Youn, B. (2024). LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy. Molecular Therapy, Preprints. https://doi.org/10.1016/j.ymthe.2018.10.015

Chicago

Park, Gaeul, Beomseok Son, JiHoon Kang, Sungmin Lee, Jaewan Jeon, Joo-Hyung Kim, Gi-Ra Yi, et al. 2024. “LDR-Induced MiR-30a and MiR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy.” Molecular Therapy, no. Preprints (January). doi:10.1016/j.ymthe.2018.10.015.